Coronavirus Delhi
Delhi has continued to report over 20,000 cases yet another day with a nearly devastated health sector lacking testing facilities, medicines, beds, oxygen, and plasma. The situation is undoubtedly grim especially for the poor, not-so-well connected people who are left at the mercy of the government hospitals lacking all of the aforementioned facilities.
Scientists from the Indian Institute of Technology, Kanpur and Hyderabad have predicted that the ongoing second wave of Covid19 in India may see its peak in mid-may with cases reaching up to 10 lakhs. They applied the SUTRA model (Susceptible, Undetected, Tested (positive), and Removed Approach) while predicting. It is a scaring sharp slope but scientists predict that it would be equally sharp coming down the way too.
Updated:
Active infections to touch 38-48 lakh between May 14-18, says SUTRA model
Share Article
AAA
Healthcare workers outside Sardar Patel COVID care centre, in New Delhi on April 26, 2021.
| Photo Credit: Shiv Kumar Pushpakar
Active infections to touch 38-48 lakh between May 14-18, says SUTRA model
Active cases in the ongoing second COVID-19 wave in India may peak at 38-48 lakh between May 14-18 and daily new infections could hit a high of 4.4 lakh from May 4-8, according to a mathematical model by IIT scientists, who have revised their projections upwards.
India on Monday saw a single-day rise of 3,52,991 (3.52 lakh) COVID-19 infections and 2,812 fatalities with 28,13,658 (28.13 lakh) active cases.
Share
New Delhi: The Indian Institute of Technology-Kanpur (IIT-K) has collaborated with I2Cure (P) Ltd, a ‘Make in India for the world’ Biotech company for all future research on Molecular iodine-based products that would be undertaken by the Biological Sciences & Bioengineering wing of IIT-K (https://www.iitk.ac.in/bsbe/). I2Cure is the first Biotechnology Company in the world to produce Molecular Iodine-based i2cure BioShield’, which is a broad-spectrum antimicrobial with proven efficacy of 99.999% against the SARS2 Covid virus.
Under the terms of the agreement, I2Cure future products would be incubated at IIT-Kanpur. The relationship would be of the equity partners, and validations of Dr. Jack Kessler’s global research would be done for Indian conditions at IIT-K. IIT-K would also work with I2Cure to develop new ‘Made in India’ products for global markets, especially in tackling long-term problems in the space of Human Preventive Health, Veterinary science (FMD,
The IIT researchers had last week reportedly predicted that the pandemic may peak between May 11-15 with 33-35 lakh total active cases and decline steeply by the end of May. Earlier this month, their modelling approach projected that active infections in the country would peak by April 15, which didn't come true.
IIT Madras Researchers Study High Transmission Potential Of Coronavirus ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.